This report from Life Science Intelligence provides the latest market data for the Global Vertebroplasty and Kyphoplasty Devices Market. Information covered by this report includes:
The global market for vertebroplasty and kyphoplasty devices is expected to reach an estimated $826.8 million in 2020 and is projected to increase at a CAGR (2020-2024) of 11.7%. Product segments covered by this report include vertebroplasty and kyphoplasty cement and delivery devices.
This report covers the impact of COVID-19 on the vertobroplasty and kyphoplasty devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Merit Medical, Medtronic, and Stryker and others. The report provides insights into trends, drivers, and limiters of the vertebroplasty and kyphoplasty devices market, as well as highlights potential opportunities.
Vertebroplasty and kyphoplasty procedures have been negatively impacted by the COVID-19 pandemic. Procedure volumes are projected to pre-COVID procedure levels by Q2 or Q3 of 2021. The procedures are expected to surge by the end of 2021 as backlog surgeries and newly diagnosed cases are scheduled.
The vertebroplasty and kyphoplasty market has been dominated by Medtronic for over a decade. It is estimated that sales of Medtronic’s vertebroplasty and kyphoplasty account for 90% of global product sales. Medtronic has been able to maintain its leadership in this market through its innovation-driven Kyphon platform.